Trials / Completed
CompletedNCT01126424
A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability
A Study to Compare the Cognitive Effect of Solifenacin 5mg Once-daily and Oxybutynin 5mg Twice-daily After Chronic Dosing Versus Placebo in Subjects 75 Years and Over With Mild Cognitive Impairment - A Double-blind, Randomized, Multi-center Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose is to compare solifenacin and oxybutynin with an inactive tablet and assess any potential effects on mental ability.
Detailed description
All subjects will receive each intervention during the course of the study. Subjects will complete a 21-day washout period between treatment periods and following last treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solifenacin | tablet |
| DRUG | Oxybutynin | capsule |
| DRUG | Placebo | tablet |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-05-19
- Last updated
- 2012-10-15
- Results posted
- 2012-10-15
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01126424. Inclusion in this directory is not an endorsement.